Predictors of response to reinduction chemotherapy for patients with acute myeloid leukemia who do not achieve complete remission with frontline induction chemotherapy-Reference-Cited by-同舟云学术

Predictors of response to reinduction chemotherapy for patients with acute myeloid leukemia who do not achieve complete remission with frontline induction chemotherapy

Published:2007 Issue:1 Volume:83 Page:54-58
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am. J. Hematol.

Author:

Brandwein Joseph M.,Gupta Vikas,Schuh Andre C.,Schimmer Aaron D.,Yee Karen,Xu Wei,Messner Hans A.,Lipton Jeffrey H.,Minden Mark D.

Publisher

Wiley

Subject

Hematology

Reference16 articles.

1. Drug therapy for acute myeloid leukemia

2. The Importance of Diagnostic Cytogenetics on Outcome in AML: Analysis of 1,612 Patients Entered Into the MRC AML 10 Trial

3. The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial

4. Disease biology rather than age is the most important determinant of survival of patients ≥ 60 years with acute myeloid leukemia treated with uniform intensive therapy

5. Mitoxantrone versus daunorubicin in induction-consolidation chemotherapy--the value of low-dose cytarabine for maintenance of remission, and an assessment of prognostic factors in acute myeloid leukemia in the elderly: final report. European Organization for the Research and Treatment of Cancer and the Dutch-Belgian Hemato-Oncology Cooperative Hovon Group.

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pain in patients with newly diagnosed or relapsed acute leukemia;Supportive Care in Cancer;2018-12-08

2. AML refractory to primary induction with Ida-FLAG has a poor clinical outcome;Leukemia Research;2018-05

3. Are we curing more older adults with acute myeloid leukemia with allogeneic transplantation in CR1?;Current Opinion in Hematology;2016-03

4. miR-126 Regulates Distinct Self-Renewal Outcomes in Normal and Malignant Hematopoietic Stem Cells;Cancer Cell;2016-02

5. Quality of life and physical function in adults treated with intensive chemotherapy for acute myeloid leukemia improve over time independent of age;Journal of Geriatric Oncology;2015-07